Published on in Vol 10, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29695, first published .
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

Journals

  1. Soares M, Gonçalves R, Vasques J, da Silva-Junior A, Gubert F, Santos G, de Santana T, Almeida Sampaio G, Silva D, Dominici M, Mendez-Otero R. Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases. Frontiers in Molecular Neuroscience 2022;15 View
  2. Calvo B, Schembri-Wismayer P, Durán-Alonso M. Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective. Cells 2025;14(5):347 View
  3. Bi W, Cai S, Zhou L, Zheng J, Cui Y, Li Y, Liu S, Chen H, Sha S, Li J, Ma Q, Bao Z, Xing C, Du H, Wang L. Integrated Microfluidic Hydrogel‐Enhanced Microwell Array for Uniform Self‐Assembly, Long‐Term Culture, and Neural Differentiation of Mesenchymal Stem Cell Spheroids. Advanced Functional Materials 2025 View